|Bid||210.00 x 100|
|Ask||211.64 x 300|
|Day's range||227.03 - 230.95|
|52-week range||158.02 - 248.97|
|PE ratio (TTM)||46.59|
|Earnings date||23 Apr 2018 - 27 Apr 2018|
|Forward dividend & yield||N/A (N/A)|
|1y target est||257.61|
An Ivy League school says it got short-changed by a business partner in the settlement of a patent dispute over techniques to analyze DNA.
On a per-share basis, the San Diego-based company said it had net income of 46 cents. Earnings, adjusted for one-time gains and costs, were $1.44 per share. The results surpassed Wall Street expectations. ...
Homebuilders continued to sell off, while oil, steel and fertilizer stocks led the sell-off. Apple has given back most of its recent breakout gains.
Illumina (ILMN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Illumina, Inc. announced today that a federal jury in San Francisco has ruled in its favor in a patent infringement suit filed against Ariosa Diagnostics, Inc., now owned by Roche.
Jim Cramer listed the J.P. Morgan's Healthcare Conference's best and worst performers judging by the stock market's reaction.
Illumina, Inc. today announced that it will issue results for fourth quarter and fiscal year 2017 following the close of market on Tuesday, January 30, 2018.
On a record day for the indexes, Illumina stock rose on a product announcement and positive outlook, and e.l.f. Beauty fell following a lowered growth forecast.
Thermo Fisher Scientific and Illumina, Inc. today announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq technology to researchers who conduct scientific studies on Illumina’s next-generation sequencing platforms.
Illumina, Inc. announced today the launch of the iSeq™ 100 Sequencing System. The new, next-generation sequencing system delivers exceptional data accuracy, at a low capital cost, making Illumina technology available to virtually any lab.
Illumina, the dominant maker of DNA sequencers that are used in drug discovery, medicine, and biological research, is unveiling a new toy: A $19,900, one-cubic-foot box that puts DNA sequencing in the reach of many more scientists.
Jan 8 (Reuters) - Guangzhou Kingmed Diagnostics Group Co Ltd : * SAYS UNIT SIGNS AGREEMENT WITH ILLUMINA TO BUY GENES-RELATED TESTING EQUIPMENT SUCH AS MINISEQ Source text in Chinese: http://bit.ly/2m8GPFr ...